GHRS
GH Research PLC Ordinary Shares (GHRS)
$
35About GH Research PLC Ordinary Shares (GHRS)
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
Details
Daily high
$11.40
Daily low
$10.73
Price at open
$10.97
52 Week High
$20.50
52 Week Low
$6.00
Market cap
704.0M
Dividend yield
0.00%
Volume
11
Avg. volume
329,521
P/E ratio
-15.16
GH Research PLC Ordinary Shares News
Details
Daily high
$11.40
Daily low
$10.73
Price at open
$10.97
52 Week High
$20.50
52 Week Low
$6.00
Market cap
704.0M
Dividend yield
0.00%
Volume
11
Avg. volume
329,521
P/E ratio
-15.16